• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性鼻窦恶性肿瘤挽救性手术的预后指标

Prognostic Indicators for Salvage Surgery of Recurrent Sinonasal Malignancy.

作者信息

Kaplan Daniel James, Kim Jee Hong, Wang Eric, Snyderman Carl

机构信息

University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

出版信息

Otolaryngol Head Neck Surg. 2016 Jan;154(1):104-12. doi: 10.1177/0194599815606699. Epub 2015 Sep 30.

DOI:10.1177/0194599815606699
PMID:26424747
Abstract

OBJECTIVE

Identify prognostic factors after salvage surgery for recurrent sinonasal malignancy (SNM).

STUDY DESIGN

Case series with chart review.

SETTING

University of Pittsburgh Medical Center.

SUBJECTS

Forty-two patients who underwent curative surgery for locally recurrent SNM ± adjuvant therapy from June 5, 2000, to December 19, 2012. Patients without follow-up were excluded.

METHODS

Chart review with established prognostic indicators for primary malignancies. Statistical analysis included Kaplan-Meier log-rank test, Fisher's exact test, Student's t test, and Cox regression.

RESULTS

Forty-two patients met inclusion criteria: 38.5% developed a second recurrence, and 21.4% had metastases following treatment. The average disease-free interval (DFI) was 26.9 months (range, 2-90 months). DFI was significantly affected by ethmoid versus nonethmoid site (P = .049), histology (P = .012), carotid artery involvement (P = .008), perineural extension (P = .006), and clival invasion (P = .015). The overall survival rates at 6 months, 12 months, and 5 years following surgery were 83.3%, 69%, and 47.6%, respectively. Survival was affected by histology (P = .014), stratified grade (P = .042), tumor extension into the orbit (P = .019), carotid artery (P = .001), perineural space (P = .028), and clivus (P = .022). Complications occurred in 28.6% of patients and were associated with histology (P = .04). Length of hospital stay related to treatment was affected by histology (P = .009), grade (P = .013), and postoperative complication (P < .001). The median percentage of time hospitalized was 8%, and 43% of patients who died within 12 months spent >10% of their remaining days in the hospital.

CONCLUSION

High-risk histologic subtype (melanoma, sinonasal undifferentiated carcinoma, adenocarcinoma, neuroendocrine cancer, sarcoma, and squamous cell carcinoma), grade, and orbital and skull base involvement negatively affect survival and/or DFI for patients with local recurrence of SNM. Improved stratification of patients can be used to guide decision making for patients with recurrent SNM and to avoid inappropriate surgery.

摘要

目的

确定复发性鼻窦恶性肿瘤(SNM)挽救性手术后的预后因素。

研究设计

病历回顾的病例系列研究。

研究地点

匹兹堡大学医学中心。

研究对象

2000年6月5日至2012年12月19日期间接受局部复发性SNM根治性手术及±辅助治疗的42例患者。排除无随访资料的患者。

方法

采用原发性恶性肿瘤既定的预后指标进行病历回顾。统计分析包括Kaplan-Meier对数秩检验、Fisher精确检验、Student t检验和Cox回归分析。

结果

42例患者符合纳入标准:38.5%出现二次复发,21.4%在治疗后发生转移。平均无病生存期(DFI)为26.9个月(范围2 - 90个月)。筛窦与非筛窦部位(P = 0.049)、组织学类型(P = 0.012)、颈动脉受累情况(P = 0.008)、神经周围侵犯(P = 0.006)和斜坡侵犯(P = 0.015)对DFI有显著影响。术后6个月、12个月和5年的总生存率分别为83.3%、69%和47.6%。生存率受组织学类型(P = 0.014)、分层分级(P = 0.042)、肿瘤侵犯眼眶(P = 0.019)、颈动脉(P = 0.001)、神经周围间隙(P = 0.028)和斜坡(P = 0.022)影响。28.6%的患者发生并发症,且与组织学类型有关(P = 0.04)。与治疗相关的住院时间受组织学类型(P = 0.009)、分级(P = 0.013)和术后并发症(P < 0.001)影响。住院时间的中位数百分比为8%,12个月内死亡的患者中有43%在剩余时间里有超过10%的时间住院。

结论

高危组织学亚型(黑色素瘤、鼻窦未分化癌、腺癌、神经内分泌癌、肉瘤和鳞状细胞癌)、分级以及眼眶和颅底受累对局部复发性SNM患者的生存和/或DFI有负面影响。改进患者分层可用于指导复发性SNM患者的决策,并避免不适当的手术。

相似文献

1
Prognostic Indicators for Salvage Surgery of Recurrent Sinonasal Malignancy.复发性鼻窦恶性肿瘤挽救性手术的预后指标
Otolaryngol Head Neck Surg. 2016 Jan;154(1):104-12. doi: 10.1177/0194599815606699. Epub 2015 Sep 30.
2
Extended orbital exenteration for sinonasal malignancy with orbital apex extension: surgical technique and clinical analysis.鼻窦恶性肿瘤侵犯眶尖的扩大眼眶内容剜除术:手术技术及临床分析
J Neurosurg. 2015 Jul;123(1):52-8. doi: 10.3171/2014.9.JNS141256. Epub 2015 Mar 27.
3
Endoscopic and open surgical approaches to locally advanced sinonasal melanoma: comparing the therapeutic benefits.局部晚期鼻窦黑色素瘤的内镜手术与开放手术方法:治疗效果比较
JAMA Otolaryngol Head Neck Surg. 2014 Sep;140(9):840-5. doi: 10.1001/jamaoto.2014.1321.
4
Multicenter study to assess endoscopic resection of 159 sinonasal adenocarcinomas.评估159例鼻窦腺癌内镜切除术的多中心研究。
Ann Surg Oncol. 2014 Apr;21(4):1384-90. doi: 10.1245/s10434-013-3385-8. Epub 2013 Nov 22.
5
Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results.有或无开颅手术的鼻窦癌内镜切除术:肿瘤学结果
Arch Otolaryngol Head Neck Surg. 2009 Dec;135(12):1219-24. doi: 10.1001/archoto.2009.173.
6
Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma.头颈部原发性黏膜黑色素瘤。口腔和鼻腔黑色素瘤的临床表现和组织病理学特征比较。
Oral Oncol. 2008 Nov;44(11):1039-46. doi: 10.1016/j.oraloncology.2008.01.014. Epub 2008 Apr 8.
7
Adenoid cystic carcinoma of the paranasal sinuses: retrospective series and review of the literature.鼻腔鼻窦腺样囊性癌:回顾性系列研究和文献复习。
Eur Ann Otorhinolaryngol Head Neck Dis. 2013 Nov;130(5):257-62. doi: 10.1016/j.anorl.2012.09.010. Epub 2013 Jun 6.
8
Outcomes of Primary Versus Salvage Surgery for Sinonasal Malignancies: A Population-Based Analysis.原发性与挽救性手术治疗鼻窦恶性肿瘤的结局:基于人群的分析。
Laryngoscope. 2021 Mar;131(3):E710-E718. doi: 10.1002/lary.28925. Epub 2020 Jul 24.
9
Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 31 patients and prognostic factors.复发性鼻咽癌的鼻咽切除术:31例患者回顾及预后因素分析
Laryngoscope. 2002 Oct;112(10):1877-82. doi: 10.1097/00005537-200210000-00033.
10
Adenoid cystic carcinoma of the sinonasal tract: treatment results.鼻窦腺样囊性癌:治疗结果
Laryngoscope. 2006 Jun;116(6):982-6. doi: 10.1097/01.mlg.0000216900.03188.48.

引用本文的文献

1
Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.鼻窦恶性肿瘤:ESMO-EURACAN诊断、治疗及随访临床实践指南
ESMO Open. 2025 Feb;10(2):104121. doi: 10.1016/j.esmoop.2024.104121. Epub 2025 Feb 6.
2
Recurrent Sinonasal Squamous Cell Carcinoma: Current Insights and Treatment Advances.复发性鼻窦鳞状细胞癌:当前见解与治疗进展
Cancers (Basel). 2024 Dec 24;17(1):4. doi: 10.3390/cancers17010004.
3
Clinical Outcome in Patients with Large Sinonasal Tumors with Intracranial Extension.
伴有颅内侵犯的大型鼻窦肿瘤患者的临床结局
J Neurol Surg B Skull Base. 2023 May 24;85(4):347-357. doi: 10.1055/a-2082-4951. eCollection 2024 Aug.
4
Real-Life Prognosis of Sinonasal Tumors.鼻窦肿瘤的实际预后
J Pers Med. 2024 Apr 24;14(5):444. doi: 10.3390/jpm14050444.
5
Results of Primary Treatment and Salvage Treatment in the Management of Patients with Non-Squamous Cell Malignant Tumors of the Sinonasal Region: Single Institution Experience.鼻窦区域非鳞状细胞恶性肿瘤患者治疗中初始治疗和挽救性治疗的结果:单机构经验
J Clin Med. 2023 Mar 1;12(5):1953. doi: 10.3390/jcm12051953.
6
The contemporary management of cancers of the sinonasal tract in adults.成人鼻窦肿瘤的当代治疗方法。
CA Cancer J Clin. 2023 Jan;73(1):72-112. doi: 10.3322/caac.21752. Epub 2022 Aug 2.
7
Salvage surgery in recurrent sinonasal cancers: Proposal for a prognostic model based on clinicopathologic and treatment-related parameters.复发性鼻窦鼻腔癌症的挽救性手术:基于临床病理和治疗相关参数的预后模型的建议。
Head Neck. 2022 Aug;44(8):1857-1870. doi: 10.1002/hed.27102. Epub 2022 Jun 2.
8
The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours.鼻-鼻窦恶性肿瘤的开放性和内镜手术选择。
Adv Ther. 2022 Jun;39(6):2379-2397. doi: 10.1007/s12325-022-02080-x. Epub 2022 Mar 30.
9
-Intact Sinonasal Carcinoma with Rhabdoid Features.具有横纹肌样特征的完整鼻窦癌。
Case Rep Otolaryngol. 2021 Nov 18;2021:6075130. doi: 10.1155/2021/6075130. eCollection 2021.
10
Sinonasal Squamous Cell Carcinoma, a Narrative Reappraisal of the Current Evidence.鼻窦鳞状细胞癌:当前证据的叙述性重新评估
Cancers (Basel). 2021 Jun 7;13(11):2835. doi: 10.3390/cancers13112835.